September’s cost-cutting efforts at Bruker Bioscience, which included the layoff of 60 of its 1,200 employees and other restructuring moves expected to save $6 million a year, were apparently not enough, CEO Frank Laukien said last week in the company’s quarterly conference call with analysts and investors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.